Delivery Order SPE2DB22D3016-SPE2DB25FAZR9
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,193.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) to support federal medical procurement needs. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $4,938.18 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,944.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of NovoLog 100 Unit/mL vials (10mL). This is a non-set-aside contract with an ultimate completion date of June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $6,102.42 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,701.76 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a...
- The Defense Logistics Agency (DLA) awarded a $1,916.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 unit/mL vials (10 mL) on July 11, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,275.43 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL), an insulin product used in diabetes management. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of NovoLog 100 Unit/mL Vial 10mL insulin medication with a ceiling value of $1,354.18. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million through December 2026. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.92 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on June 18, 2025, with an ultimate completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NovoLog 100 Unit/mL vials (10 mL) with a ceiling value of $2,515.17. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The place of performance is AmerisourceBergen's corporate office...